Type
1.
Da Silva JC, De Oliveira RA, Santos LFS, Pascoal LM, Santos FS, Costa ACP de J, et al. Factors associated with multibacillary leprosy in a region of northeastern Brazil. Journal of infection in developing countries [Internet]. 2023;17(6):846-53. Available from: https://jidc.org/index.php/journal/article/view/37406066/3111
Type
1.
Spitz CN, Pitta IJR, Andrade LR, Sales AM, Sarno EN, Villela NR, et al. Case report: Injected corticosteroids for treating leprosy isolated neuritis. Frontiers in medicine [Internet]. 2023;10:1-6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313350/pdf/fmed-10-1202108.pdf
Type
1.
Radtke KK, Hill J, Schoenmakers A, Mulder C, Van Der Grinten E, Overbeek F, et al. Predicted pharmacokinetic interactions between hormonal contraception and single or intermittently dosed rifampicin. Journal of clinical pharmacology. 2023;
Type
1.
Falcão MML, Passos-Soares JS, Machado PRL, Gomes-Filho IS, de Carvalho LP, de Campos EJ, et al. The leprosy reaction is associated with salivary anti-Porphyromonas gingivalis IgA antibodies. AMB Express [Internet]. 2023;13(1):1-8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328877/pdf/13568_2023_Article_1576.pdf
Type
1.
Vijayvergiya G, Panwar H, Santosh T, Patra S, Joshi D, Asati DP, et al. Atypical Hansen’s Disease Mimicking Xanthogranuloma: Role of Cytology. Journal of cutaneous and aesthetic surgery [Internet]. 2023;16(1):65-8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298620/?report=printable
Type
1.
Coleman M, Hill J, Timeon E, Rimon E, Bauro T, Ioteba N, et al. Effectiveness of population-wide screening and mass drug administration for leprosy control in Kiribati: the COMBINE protocol. BMJ open [Internet]. 2023;13(6):1-9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314446/pdf/bmjopen-2022-065369.pdf
Type
1.
Collin SM, Lima A, Heringer S, Sanders V, Pessotti HA, Deps P. Systematic Review of Hansen Disease Attributed to Mycobacterium lepromatosis. Emerging infectious diseases [Internet]. 2023;29(7):1376-85. Available from: https://wwwnc.cdc.gov/eid/article/29/7/pdfs/23-0024.pdf
Type
1.
Chaudhary SK, Kalita J, Misra UK. Role of Nerve Conduction Studies in Hansen’s Disease. Neurology India. 2023;71(3):458-62.
Type
1.
Muna B, Neerukonda P. Rare concurrence of lepromatous leprosy and cutaneous tuberculosis. International journal of mycobacteriology [Internet]. 2023;12(2):207-9. Available from: https://journals.lww.com/ijmy/Fulltext/2023/12020/Rare_Concurrence_of_Lepromatous_Leprosy_and.19.aspx
Type
1.
Novais DV da C, Nascimento MGB do, Lopes GL, de Brito JAG de SM, Carneiro TX, Souza GS, et al. The Correlation between Anthropometric Variables and Muscular Strength in Patients Coinfected with Leprosy and HIV. Indian journal of dermatology [Internet]. 2023;68(2):127-34. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238977/?report=printable